Compugroup Medical SE & Co. KGaA (ETR:COP) and Isra Vision (ETR:ISR) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.
Dividends
Compugroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and has a dividend yield of 0.7%. Isra Vision pays an annual dividend of €0.18 per share and has a dividend yield of 0.4%. Compugroup Medical SE & Co. KGaA pays out 33.0% of its earnings in the form of a dividend. Isra Vision pays out 41.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Compugroup Medical SE & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.
Earnings and Valuation
This table compares Compugroup Medical SE & Co. KGaA and Isra Vision's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Compugroup Medical SE & Co. KGaA | $833.08 million | 4.44 | $81.35 million | €1.51 | 45.51 |
Isra Vision | $129.31 million | 8.05 | $9.43 million | €0.43 | 110.39 |
Compugroup Medical SE & Co. KGaA has higher revenue and earnings than Isra Vision. Compugroup Medical SE & Co. KGaA is trading at a lower price-to-earnings ratio than Isra Vision, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Compugroup Medical SE & Co. KGaA and Isra Vision's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Compugroup Medical SE & Co. KGaA | N/A | N/A | N/A |
Isra Vision | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent recommendations for Compugroup Medical SE & Co. KGaA and Isra Vision, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Compugroup Medical SE & Co. KGaA | 1 | 2 | 1 | 0 | 2.00 |
Isra Vision | 1 | 0 | 0 | 0 | 1.00 |
Compugroup Medical SE & Co. KGaA currently has a consensus target price of €82.75, suggesting a potential upside of 20.10%. Isra Vision has a consensus target price of €50.00, suggesting a potential upside of 5.09%. Given Compugroup Medical SE & Co. KGaA's stronger consensus rating and higher possible upside, equities analysts clearly believe Compugroup Medical SE & Co. KGaA is more favorable than Isra Vision.
Summary
Compugroup Medical SE & Co. KGaA beats Isra Vision on 8 of the 10 factors compared between the two stocks.